Plain-English translation of NCT06959797 on ClinicalTrials.gov ↗ ·
This study doesn't follow the usual testing phases — it may be an observational study or a different type of research.
This study compares two ways of delivering insulin to people with type 2 diabetes who already use insulin pumps. One approach is a traditional pump where you manually adjust your insulin doses, and the other uses an automatic system called CamAPS HX that adjusts your insulin continuously based on your blood sugar readings. The goal is to see if the automatic system works better, is safer, and improves your quality of life compared to the manual pump.
People using insulin pumps have to actively manage their insulin doses throughout the day, which can be stressful and time-consuming. An automatic system that adjusts insulin on its own could reduce this burden and help keep blood sugar levels in a healthier range with less effort.
You likely qualify if…
You likely don't qualify if…
You will be randomly assigned to start with either the automatic system or the manual pump for 12 weeks, then switch to the other treatment for another 12 weeks after a short break. During each 12-week period, you'll wear the same glucose sensor and use the same pump hardware, but with different settings. You'll visit the study center at the start and end of each treatment period, and the researchers will track your blood sugar levels, insulin use, and how you feel about each system.
AI-generated summary from trial data · Jul 7, 2026 · Not medical advice
France